Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Immunovant, Inc. (IMVT)

28.59 +0.97 (+3.51%)
At close: October 20 at 4:00:01 PM EDT
Trade IMVT on Coinbase
Chart Range Bar
Loading chart for IMVT
  • Previous Close 27.62
  • Open 27.76
  • Bid 20.83 x 200
  • Ask 35.50 x 200
  • Day's Range 27.62 - 29.12
  • 52 Week Range 18.51 - 45.42
  • Volume 1,440,031
  • Avg. Volume 1,321,568
  • Market Cap (intraday) 5.905B
  • Beta (5Y Monthly) 0.84
  • PE Ratio (TTM) --
  • EPS (TTM) -2.82
  • Earnings Date (est.) Nov 9, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 48.88
  • Zacks Rating Bearish

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

immunovant.com

315

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 10/20/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IMVT
12.47%
S&P 500 (^GSPC)
12.67%

1-Year Return

IMVT
48.75%
S&P 500 (^GSPC)
14.51%

3-Year Return

IMVT
18.45%
S&P 500 (^GSPC)
82.58%

5-Year Return

IMVT
235.17%
S&P 500 (^GSPC)
70.02%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue --
Earnings -153.22M
Profit Margin 0.00%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

-150M
-100M
-50M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

30.00
48.88 Average
28.59 Current
66.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/4/2026
Analyst JP Morgan
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 47 -> 50

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    7.13B

  • Enterprise Value

    6.23B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    9.70

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -46.73%

  • Return on Equity (ttm)

    -80.10%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -538.22M

  • Diluted EPS (ttm)

    -2.82

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    797.8M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -238.7M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

28.59 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 06/29/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 04/14/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 07/11/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 04/22/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: